BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 18378533)

  • 1. Professional challenges in cancer genetic testing: who is the patient?
    Chan-Smutko G; Patel D; Shannon KM; Ryan PD
    Oncologist; 2008 Mar; 13(3):232-8. PubMed ID: 18378533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
    Dickens BM; Pei N; Taylor KM
    CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How families communicate about HNPCC genetic testing: findings from a qualitative study.
    Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mother still knows best: cancer-related gene mutations, familial privacy, and a physician's duty to warn.
    Brownrigg A
    Fordham Urban Law J; 1999 Jan; 26(2):247-79. PubMed ID: 16437785
    [No Abstract]   [Full Text] [Related]  

  • 9. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in communication of genetic risk for hereditary breast cancer.
    Mackenzie A; Patrick-Miller L; Bradbury AR
    Breast J; 2009; 15 Suppl 1():S25-32. PubMed ID: 19775327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
    Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
    Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
    Prucka SK; McIlvried DE; Korf BR
    Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlations between the patient's genotype and the course of the disease in hereditary cancer diseases].
    Bisgaard ML
    Ugeskr Laeger; 2006 Jun; 168(24):2341-4. PubMed ID: 16822416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
    Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
    Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer genetics in primary care.
    Culler D; Grimes SJ; Acheson LS; Wiesner GL
    Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic testing for cancer susceptibility: the present situation in Japan].
    Miki Y
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):930-7. PubMed ID: 9212800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-based screening for colorectal cancer: The Australian perspective.
    Leggett BA
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic torts: the law of the future -- the duty of physicians to disclose the presence of a genetic disease to the relatives of their patients with the disease.
    Deftos LJ
    Univ San Francisco Law Rev; 1997; 32(1):105-37. PubMed ID: 11660530
    [No Abstract]   [Full Text] [Related]  

  • 20. Camping trips and family trees: must Tennessee physicians warn their patients' relatives of genetic risks?
    Parker CM
    Tenn Law Rev; 1998; 65(2):585-618. PubMed ID: 11863017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.